The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...
Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...
Long-term stabilizing of retinal exudation and fluid accumulation contributes to brolucizumab’s efficacy in managing wet age-related macular degeneration (AMD). Visual prognosis could be improved when ...
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...
The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was supported by positive 1-year data from the phase 3 Pagoda study, in which Susvimo ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Woman's World on MSN1h
Judi Dench Talks Fading Eyesight-She Can't Walk Alone or ‘I Will Fall Over'From her Oscar-winning turn as Queen Elizabeth I in Shakespeare in Love to her famously gender-swapped role as "M" in the ...
Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular degeneration.
Genentech unit has received FDA approval for its drug Susvimo 100 mg/mL injection for the treatment of diabetic macular edema, a leading cause of blindness for people with diabetes. Susvimo, also ...
Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback